N/A
Completed N=60
mHealth Technologies to Enhance PrEP Adherence Among Thai MSM
Adherence, Patient · Pre-Exposure Prophylaxis · HIV
Source: ClinicalTrials.gov NCT04413708 ↗
Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcomePrimary: Intervention Feasibility: Average Number of Days of Any App Use — 68 days
Summary
This study aims to: 1) adapt the theory-based P3 (Prepared, Protected, emPowered) app designed to improve pre-exposure prophylaxis (PrEP) adherence, retention in PrEP clinical care, and PrEP persistence among young gay, bisexual, and other men who have sex with men (YMSM) in the United States for YMSM in Thailand, and 2) conduct a pilot randomized controlled trial (RCT) to assess the feasibility, acceptability, and potential impact of the adapted P3-Thailand (P3-T) app.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Intervention Feasibility: Average Number of Days of Any App Use |
68 | — |
| PRIMARY Intervention Feasibility: Average Number of Days of PrEP Medication Tracked Through App |
60 | — |
| PRIMARY Intervention Acceptability: Mean Intervention Acceptability, Composite Score CSQ-8 |
25.18 | — |
| SECONDARY Difference in PrEP Medication Adherence Between Study Arms at Month 3 |
27; 23 | 0.41 |
| SECONDARY Difference in PrEP Medication Adherence Between Study Arms at Month 6 |
21; 18 | 1.0 |
Eligibility Criteria
Inclusion Criteria
- Male sex at birth
- Gender identity is male
- Identify as a man who has sex with men
- Ages 16-24
- Plan to start PrEP in next 14 days
- Able to speak and read Thai
- Own an Android or iOS smartphone
Exclusion Criteria
- Currently participating in another experimental PrEP adherence intervention
- Plan to move out of Bangkok in the next 6 months
- Unable to be consented due to an active substance use or psychological condition
Data sourced from ClinicalTrials.gov (NCT04413708). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.